Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 79
Filter
4.
Int J Immunopathol Pharmacol ; 26(1): 247-50, 2013.
Article in English | MEDLINE | ID: mdl-23527729

ABSTRACT

Morniflumate is the morpholinoethyl ester of niflumic acid, a non-steroidal anti-inflammatory drug, derived from nicotinic acid. We studied 112 patients who had experienced cutaneous reactions after using non-steroidal anti-inflammatory drugs. Only two of all the patients who underwent an oral challenge with morniflumate had a positive result to the test. By demonstrating the low incidence of reactions to morniflumate through oral challenges, we suggest that patients with non-steroidal anti-inflammatory drug hypersensitivity may tolerate this drug which would therefore be a useful alternative.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Niflumic Acid/analogs & derivatives , Adolescent , Adult , Aged , Aged, 80 and over , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Drug Eruptions/etiology , Female , Humans , Hypersensitivity, Immediate/etiology , Male , Middle Aged , Niflumic Acid/administration & dosage , Young Adult
7.
Int Arch Allergy Immunol ; 159(2): 147-8, 2012.
Article in English | MEDLINE | ID: mdl-22653559

ABSTRACT

We present the cases of 5 patients with a positive clinical history of cutaneous symptoms due to contact with latex products. A latex allergological assessment was made through skin prick tests (SPTs) both with commercial latex extracts and extemporaneous glove extracts, and serum-specific IgE to latex and glove-use tests. In addition, serum-specific IgE to recombinant allergens for Hevea brasiliensis was dosed. Molecular diagnostics in association with the glove-use test and, to a lesser extent, the SPTs with glove eluate are useful diagnostic tests to confirm the diagnosis of latex allergy in patients with mucocutaneous symptoms.


Subject(s)
Allergens/immunology , Antigens, Plant/immunology , Chitinases/immunology , Latex Hypersensitivity/diagnosis , Latex Hypersensitivity/immunology , Latex/immunology , Plant Proteins/immunology , Adult , Cross Reactions , Female , Hevea/immunology , Humans , Immunoglobulin E/blood , Male , Middle Aged , Skin Tests
9.
Int J Immunopathol Pharmacol ; 24(4): 1115-8, 2011.
Article in English | MEDLINE | ID: mdl-22230421

ABSTRACT

Acquired angioedema (AAE) with C1 inhibitor deficiency is often associated to B cell lymphoproliferative disorders or autoimmune diseases. We report a case of AAE associated with IgM anti-cardiolipin antibodies, with frequent edematous attacks, that disappeared completely after a slight immunosuppression and danazol therapy.


Subject(s)
Angioedema/immunology , Antibodies, Anticardiolipin/blood , Complement C1 Inactivator Proteins/deficiency , Immunoglobulin M/blood , Aged , Angioedema/diagnosis , Angioedema/drug therapy , Azathioprine/therapeutic use , Complement C1 Inhibitor Protein , Danazol/therapeutic use , Female , Humans , Immunosuppressive Agents/therapeutic use , Ticlopidine/therapeutic use , Treatment Outcome
13.
Int J Immunopathol Pharmacol ; 22(4): 1131-4, 2009.
Article in English | MEDLINE | ID: mdl-20074479

ABSTRACT

Non-steroidal anti-inflammatory drugs frequently cause adverse reactions. This retrospective study was based on analysis of the data obtained from interviews conducted with 173 patients, who underwent and tolerated a challenge test with etoricoxib (a selective cyclooxigenase 2 enzyme inhibitor). Only one of 82 patients who were treated with etoricoxib reported reactions. We can conclude that etoricoxib shows a high long-term tolerability in patients with non-steroidal anti-inflammatory drug hypersensitivity.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Cyclooxygenase 2 Inhibitors/therapeutic use , Drug Hypersensitivity/etiology , Pyridines/therapeutic use , Sulfones/therapeutic use , Administration, Oral , Adolescent , Adult , Aged , Aged, 80 and over , Cyclooxygenase 2 Inhibitors/administration & dosage , Cyclooxygenase 2 Inhibitors/adverse effects , Etoricoxib , Female , Humans , Male , Middle Aged , Pyridines/administration & dosage , Pyridines/adverse effects , Retrospective Studies , Single-Blind Method , Sulfones/administration & dosage , Sulfones/adverse effects , Young Adult
17.
Int J Immunopathol Pharmacol ; 21(1): 233-5, 2008.
Article in English | MEDLINE | ID: mdl-18336751

ABSTRACT

The group of non-steroidal anti-inflammatory drugs (NSAIDs) is commonly involved in hypersensitivity reactions. In clinical practice the physician is often faced with the need to choose an alternative anti-inflammatory agent for a patient who has suffered a hypersensitivity reaction to a NSAID. The most common approach to choosing the safest NSAID is to perform a challenge test. Parecoxib is the first injectable COX-2 selective inhibitor indicated for the treatment of acute postoperative pain. The authors report the case of a patient with a history of cutaneous adverse reactions to different classes of NSAIDs, including selective COX-2 inhibitors, who underwent and tolerated challenge with parecoxib.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Cyclooxygenase 2 Inhibitors/adverse effects , Cyclooxygenase Inhibitors/therapeutic use , Drug Hypersensitivity/etiology , Isoxazoles/therapeutic use , Female , Humans , Middle Aged
18.
J Asthma Allergy ; 2: 17-23, 2008 Dec 16.
Article in English | MEDLINE | ID: mdl-21437140

ABSTRACT

Levocetirizine is the pharmacologically active enantiomer of cetirizine. It is a potent histamine H-1 receptor antagonist with anti-inflammatory and antiallergic properties. The review analyses the levocetirizine's properties in terms of safety and efficacy both in allergic rhinitis and urticarioid syndromes.

SELECTION OF CITATIONS
SEARCH DETAIL
...